About Kent Lewandrowski, MD
Kent Lewandrowski, MD is the Associate Chief for Laboratory and Molecular Medicine at the Massachusetts General Hospital Pathology Service. He is a Professor of Pathology at Harvard Medical School, with research interests in pancreatic pathology and the evaluation of point-of-care technologies. Dr. Lewandrowski is a member of the leadership team of Mass General Brigham Personalized Medicine. Read more about Dr. Lewandrowski's contributions to operations improvement, regulatory compliance, strategic planning, and quality improvement. He has published several studies on the impact of rapid point-of-care testing on outcomes in the emergency department, particularly in relation to reducing emergency room length-of-stay and reducing unnecessary hospital admissions. He is editor in chief of the medical journal "Point of Care: The Journal of Near Patient Testing Technology". Dr. Lewandrowski was trained in anatomic and clinical pathology at the Massachusetts General Hospital and has been on the staff of the department of Pathology since 1991.
Clinical Interests:
- Clinical Pathology
- Point of Care Testing
Treats:
- Adult
Locations
Mass General Pathology
55 Fruit St.
Boston, MA 02114
Phone: 617-643-0800
Medical Education
- MD, UMASS Medical School
- Residency, Massachusetts General Hospital*****
American Board Certifications
- Anatomic Pathology & Clinical Pathology, American Board of Pathology
Accepted Insurance Plans
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Centene/Celticare
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- Mass General Brigham Health Plan - ACD
- Mass General Brigham Health Plan - PBO
- MassHealth
- Medicare
- Medicare - ACD
- Medicare ACO - ACD
- Medicare ACO - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Lewandrowski's research interests include point-of-care diagnostics, and serum cardiac markers. He also studies the pathology of the pancreas, including chemical and histopathologic features of pancreatic neoplasms and the pathology of acute experimental pancreatitis. For more information about research concepts, co-authors, and to see a timeline, visit Dr. Lewandrowski's profile at the Harvard Clinical and Translational Science Center.
Publications
-
- Evaluation of the i-STAT point-of-care capillary whole blood hematocrit and hemoglobin: Comparison to the Siemens RAPIDLab 1200, Sysmex XE5000, and manual spun hematocrit. Rudolf J, Douglass J, Baron J, Lewandrowski K. Clin Chim Acta. 2015 Apr 7. pii: S0009-8981(15)00179-5.[Epub ahead of print]
- "Outside-in" technique, clinical results, and indications with transforaminal lumbar endoscopic surgery: a retrospective study on 220 patients on applied radiographic classification of foraminal spinal stenosis. Lewandrowski KU.Int J Spine Surg. 2014 Dec 1;8.
- Enhanced creatinine and estimated glomerular filtration rate reporting to facilitate detection of acute kidney injury. Baron JM, Cheng XS, Bazari H, Bhan I, Lofgren C, Jaromin RT, Lewandrowski KB, Dighe AS. Am J Clin Pathol. 2015 Jan;143(1):42-9.